Where others see data,
we see answers
Our global data-sharing network generates clinically actionable insights from data to improve patient outcomes worldwide.
Where others see data,
we see answers
Our global data-sharing network generates clinically actionable insights from data to improve patient outcomes worldwide.
Democratizing data-driven medicine, together.
OUR CUSTOMER BASE
780+
Healthcare Institutions
OUR GLOBAL FOOTPRINT
70+
Countries
GENOMIC PROFILES
1.8 Million+
Genomic Profiles Analyzed
OUR CUSTOMER BASE
780+
Healthcare Institutions
OUR GLOBAL FOOTPRINT
70+
Countries
GENOMIC PROFILES
1.8 Million+
Genomic Profiles Analyzed
Retain ownership of your data.
SOPHiA DDM™: A universal healthcare analytics platform
Powered by AI and machine learning (ML), our global cloud-based platform provides a safe, secure, and instantly accessible environment to standardize, compute, and analyze digital health data, generating insights from complex multimodal data sets that have the potential to improve diagnosis, therapy selection, analysis, and drug development. Our customers perform testing on their own samples, retain custody of both their samples and data, and use the SOPHiA DDM™ Platform to analyze data and share insights with each other to grow a collective intelligence.
The SOPHiA DDM™ Platform provides analysis and insights across multiple disease areas – from oncology to inherited disorders – and is designed to continually improve as we analyze more data over time.
Expand identification of HRD positive ovarian cancers.
SOPHiA DDM™ HRD Solution combines information from germline and somatic HRR mutations (including BRCA1 and BRCA2) with a measure of genomic scarring.
Build in-house expertise on HRD testing with a decentralized workflow, retaining ownership of all data.
Latest News & Events
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Launch of new application enables global access to high-performing solid tumor profiling assay
Advancing precision oncology with MSK-ACCESS® powered with SOPHiA DDM™ – ELBS & SOPHiA GENETICS webinar (European Liquid Biopsy Society)
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, recently joined the European…
SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research
BOSTON and ROLLE, Switzerland, November 6, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine,…
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
BOSTON, United States and ROLLE, Switzerland, November 5, 2024 — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader…
SOPHiA GENETICS Reports Third Quarter 2024 Results
Clinical growth reaccelerates with record analysis volume; Cash burn improves 39% BOSTON and ROLLE, Switzerland, Nov. 5, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH),…
ESMO Asia 2024
We are thrilled to announce our participation in the ESMO Asia Congress 2024! Join the SOPHiA GENETICS team at booth…